Hims & hers将停止在诉讼解决方案下销售GLP-1复合药物, Hims & Hers will stop selling compound GLP-1 drugs under a lawsuit settlement, ending their telehealth availability.

根据法院档案,Hims & Hers Health将停止出售GLP-1复合药物,作为诉讼解决办法的一部分。 Hims & Hers Health will discontinue selling compound GLP-1 medications as part of a settlement in a lawsuit, according to a court filing. 该公司没有承认错失行为,但同意解决有关销售和分销毒品的指控的条款。 The company did not admit wrongdoing but agreed to the terms to resolve allegations related to the marketing and distribution of the drugs. 这一举动影响到其远程保健服务,并且是在对网上销售的减重和糖尿病治疗进行更多审查的情况下进行的。 The move affects its telehealth offerings and comes amid increased scrutiny of weight-loss and diabetes treatments sold online.